Filing Details
- Accession Number:
- 0001418812-10-000036
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-05-24 13:00:00
- Reporting Period:
- 2010-05-20
- Filing Date:
- 2010-05-24
- Accepted Time:
- 2010-05-24 16:51:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 736822 | Immucor Inc | BLUD | In Vitro & In Vivo Diagnostic Substances (2835) | 222408354 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1351069 | Valueact Capital Management, L.p. | 435 Pacific Avenue, 4Th Floor San Francisco CA 94133 | No | No | Yes | Yes | |
| 1351073 | Valueact Capital Management, Llc | 435 Pacific Avenue, 4Th Floor San Francisco CA 94133 | No | No | Yes | Yes | |
| 1418812 | Va Partners I, Llc | 435 Pacific Avenue, 4Th Floor San Francisco CA 94133 | No | No | Yes | Yes | |
| 1418813 | Valueact Holdings Gp, Llc | 435 Pacific Avenue, 4Th Floor San Francisco CA 94133 | No | No | Yes | Yes | |
| 1418814 | Valueact Holdings, L.p. | 435 Pacific Avenue, 4Th Floor San Francisco CA 94133 | No | No | Yes | Yes | |
| 1464912 | Valueact Capital Master Fund, L.p. | 435 Pacific Avenue 4Th Floor San Francisco CA 94133 | No | No | Yes | Yes |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2010-05-20 | 50,000 | $20.18 | 7,090,665 | No | 4 | P | Indirect | See footnotes |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-05-20 | 50,000 | $20.26 | 7,140,665 | No | 4 | P | Indirect | See footnotes |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-05-21 | 50,000 | $19.84 | 7,190,665 | No | 4 | P | Indirect | See footnotes |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-05-21 | 50,000 | $19.83 | 7,240,665 | No | 4 | P | Indirect | See footnotes |
| Common Stock, $0.10 Par Value | Acquisiton | 2010-05-24 | 100,000 | $19.78 | 7,340,665 | No | 4 | P | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnotes |
| No | 4 | P | Indirect | See footnotes |
| No | 4 | P | Indirect | See footnotes |
| No | 4 | P | Indirect | See footnotes |
| No | 4 | P | Indirect | See footnotes |
Footnotes
- The securities reported herein are directly beneficially owned by ValueAct Capital Master Fund, L.P. and may be deemed to be indirectly beneficially owned by (i) VA Partners I, LLC as General Partner of ValueAct Capital Master Fund, L.P., (ii) ValueAct Capital Management, L.P. as the manager of ValueAct Capital Master Fund, L.P., (iii) ValueAct Capital Management, LLC as General Partner of ValueAct Capital Management, L.P., (iv) ValueAct Holdings, L.P. as the sole owner of the limited partnership interests of ValueAct Capital Management, L.P. and the membership interests of ValueAct Capital Management, LLC and as the majority owner of the membership interests of VA Partners I, LLC and (v) ValueAct Holdings GP, LLC as General Partner of ValueAct Holdings, L.P.
- Each reporting person listed herein disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein, and this report shall not be deemed an admission that such person is the beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
Billionaire Hedge Funds
